|
Market Closed -
Nasdaq
01:30:00 13/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 31.42 USD | +1.85% |
|
+7.38% | +2.01% |
| 12/08 | BNP Paribas Initiates Genmab at Outperform, With $40 Price Target | MT |
| 12/08 | Nordic stocks in North America: AstraZeneca fell 1.0% | FW |
Chart: Technical Analysis
Stock exchange
Nasdaq
GMAB 31.42 $
+1.85%
11Cr
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq Copenhagen
| GMAB | 2,037.00DKK | +2.21% | 27Cr kr | |
London S.E.
| 0MGB | 2,015.75DKK | +1.64% | 3.48Cr kr | |
|
CBOE
| GMABc | 2,019.00DKK | -0.74% | 22.29L kr | |
|
Mexican S.E.
| GMAB N | 5,000.66MXN | +24.15% | 12.55L $ | |
|
Tradegate
| GE9 | 273.20EUR | +0.40% | 5.46T € | |
|
Xetra
| GE9 | 272.10PTS | +1.91% | 3.27T PTS | |
|
CBOE
| 0MGB | 2,025.00DKK | +2.30% | 22.28T kr | |
|
Boerse Muenchen
| GE9 | 272.60EUR | +0.26% | 272.6 € | |
|
Deutsche Boerse AG
| GE9 | 271.00EUR | +2.03% | 0 € | |
|
Börse Stuttgart
| GE9 | 272.80EUR | +0.59% | 0 € | |
|
Wiener Boerse
| GMAB | 267.00EUR | +0.07% | 0 € | |
|
Xetra
| GE9 | 272.10EUR | +1.91% | 0 € | |
Nasdaq
| GMAB | 31.42USD | +1.85% | 11Cr $ | |
|
CBOE
| GMAB | 31.42USD | +1.81% | 45.71L $ | |
|
Börse Stuttgart
| GE91 | 27.20EUR | 0.00% | 0 € | |
|
Tradegate
| GE91 | 27.40EUR | +2.24% | 0 € | |
|
Deutsche Boerse AG
| GE91 | 27.20EUR | +2.26% | 0 € | |
|
Boerse Muenchen
| GE91 | 27.20EUR | 0.00% | 0 € |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Charts Genmab A/S
Select your edition
All financial news and data tailored to specific country editions
